Table 2.
Results of the univariate analysis affecting the diagnosis of cervical intraepithelial neoplasia high-grade lesions (%)
| Project | CIN grade (n = 52) | CIN grade I (n = 48) | χ2 | P value |
| Age | 0.495 | 0.482 | ||
| ≥ 45 | 15 (28.8) | 17 (35.4) | ||
| < 45 | 37 (71.2) | 31 (64.6) | ||
| Gravidity | 0.031 | 0.861 | ||
| ≥ 2 | 16 (30.8) | 14 (29.2) | ||
| < 2 | 36 (69.2) | 34 (70.8) | ||
| Parity | 0.495 | 0.482 | ||
| ≥ 2 | 15 (28.8) | 17 (35.4) | ||
| < 2 | 37 (71.2) | 31 (64.6) | ||
| HPV (PCR reverse-dot hybridization) | 14.408 | < 0.001 | ||
| Positive | 36 (69.2) | 15 (31.3) | ||
| Negative | 16 (30.8) | 33 (68.7) | ||
| HPV E6/E7 mRNA | 22.960 | < 0.001 | ||
| Positive | 39 (75.0) | 13 (27.1) | ||
| Negative | 13 (25.0) | 35 (72.9) |
CIN: Cervical intraepithelial neoplasia; HPV: Human papilloma virus; PCR: Polymerase chain reaction.